SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of β-catenin.

SUMOylation has emerged as an important post-translational modification that modulates the localization, stability and activity of a broad spectrum of proteins. A dynamic process, it can be reversed by a family of SUMO- specific proteases (SENPs). However, the biological roles of SENPs in mammalian development and pathogenesis remain largely elusive. Here, we demonstrated that SENP2 plays a critical role in the control of hepatocellular carcinoma cell growth. SENP2 was found to be down-regulated in hepatocellular carcinoma (HCC) tissues and over-expression suppressed the growth and colony formation of HCC cells. In contrast, silencing of SENP2 by siRNAs promoted cancer cell growth. We further found that stability of β-catenin was markedly decreased when SENP2 was over-expressed. Interestingly, the decrease was dependent on the de-SUMOylation activity of SENP2, because over-expression of a SENP2 catalytic mutant form had no obviously effects on β-catenin. Our results suggest that SENP2 might play a role in hepatocellular carcinoma cell growth control by modulating the stability of β-catenin.

[1]  J. Abe,et al.  SUMO--a post-translational modification with therapeutic potential? , 2010, Current opinion in pharmacology.

[2]  F. Melchior,et al.  Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.

[3]  A. Vertegaal.  SUMO chains: polymeric signals. , 2010, Biochemical Society transactions.

[4]  M. Dasso,et al.  Association of the Human SUMO-1 Protease SENP2 with the Nuclear Pore* , 2002, The Journal of Biological Chemistry.

[5]  W. Hsu,et al.  Comparison of Chemotherapy Response with P-Glycoprotein, Multidrug Resistance-Related Protein-1, and Lung Resistance-Related Protein Expression in Untreated Small Cell Lung Cancer , 2005, Lung.

[6]  M. Hochstrasser,et al.  A new protease required for cell-cycle progression in yeast , 1999, Nature.

[7]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[8]  C. Cavard,et al.  Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. , 2008, Future oncology.

[9]  Xi He,et al.  Wnt/beta-catenin signaling: new (and old) players and new insights. , 2008, Current opinion in cell biology.

[10]  D. Eick,et al.  The nucleolar SUMO‐specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing , 2008, EMBO reports.

[11]  R. Schwartz,et al.  SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. , 2010, Molecular cell.

[12]  C. Gottardi,et al.  &bgr;-catenin signaling: a novel mediator of fibrosis and potential therapeutic target , 2011, Current opinion in rheumatology.

[13]  Edward T H Yeh,et al.  SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression. , 2010, Genes & cancer.

[14]  R. David.  Sumoylation: Targeting SUMO , 2010, Nature reviews. Molecular cell biology.

[15]  Jinke Cheng,et al.  Role of desumoylation in the development of prostate cancer. , 2006, Neoplasia.

[16]  Sucha Singh,et al.  Conditional β‐catenin loss in mice promotes chemical hepatocarcinogenesis: Role of oxidative stress and platelet‐derived growth factor receptor α/phosphoinositide 3‐kinase signaling , 2010, Hepatology.

[17]  M. Dasso,et al.  SUMOylation and deSUMOylation at a glance , 2009, Journal of Cell Science.

[18]  A. Chien,et al.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. , 2012, Gastroenterology.

[19]  R. Hay,et al.  SUMO-specific proteases: a twist in the tail. , 2007, Trends in cell biology.

[20]  A. Di Bacco,et al.  SUMO-Specific Proteases and the Cell Cycle , 2006, Cell cycle.

[21]  E. Yeh,et al.  Nucleocytoplasmic Shuttling Modulates Activity and Ubiquitination-Dependent Turnover of SUMO-Specific Protease 2 , 2006, Molecular and Cellular Biology.

[22]  Jinke Cheng,et al.  SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia , 2007, Cell.

[23]  Jinke Cheng,et al.  SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. , 2007, Cell.

[24]  V. Baud,et al.  Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. , 2012, The Journal of clinical investigation.

[25]  Wei Hsu,et al.  SUMO-Specific Protease 2 Is Essential for Modulating p53-Mdm2 in Development of Trophoblast Stem Cell Niches and Lineages , 2008, PLoS biology.